IF: 1.211 5-Year IF: 1.394 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38
ISSN Print: 1521-9437
Volumes:Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999
International Journal of Medicinal Mushrooms
Medicinal Properties of Substances Occurring in Higher Basidiomycetes Mushrooms: Current Perspectives (Review)
Solomon P. Wasser
N.G. Kholodny Institute of Botany, NAS of Ukraine, 2 Tereshchenkovskaya Str., Kiev 01004, Ukraine; International Center for Cryptogamic Plants and Fungi, Institute of Evolution, University of Haifa, Mount Carmel, Haifa, Israel
Alexander L. Weis
international Myko Biologies, Inc., Texas Research Park, 14785 Omicron Dr., Suite 104, San Antonio, TX, 78245, U.S.A.
This review highlights some of the recently isolated and identified substances of higher Basidiomycetes mushroom origin that express promising antitumor, immune modulating, cardiovascular and antihyper-cholesterolemia, antiviral, antibacterial, antiparasitic, hepatoprotective, and antidiabetic effects. Medicinal mushrooms have a long history of use in folk medicine. Mushrooms useful against cancers of the stomach, esophagus, lungs, etc., are known in China, Russia, Japan, and Korea, as well as the United States and Canada. There are approximately two hundred species of mushrooms that have been found to markedly inhibit the growth of different kinds of tumors. However, most of the mushroom origin antitumor substances have not been clearly defined. Several antitumor polysaccharides, such as hetero-β-glucans and their protein complexes (e.g., xyloglucans, and acidic β-glucan containing uronic acid), as well as dietary fibers, lectins, and terpenoids, have been isolated from medicinal mushrooms. In Japan, Russia, China, and the United States, several different polysaccharide antitumor agents have been developed from the fruiting body, mycelia, and culture medium of various medicinal mushrooms (Lentinus edodes, Ganoderma lucidum, Schizophyllum commune, Trametes versicolor, Inonotus obliquus, and Flammulina velutipes). Both cellular components and secondary metabolites of a large number of mushrooms have been shown to effect the immune system of the host and therefore could be used to treat a variety of disease states. The information presented in this review is helpful in exploring and understanding the rich traditions of medicinal mushrooms in Eastern and Western cultures and medicine.
KEY WORDS: Dietary fiber, higher Basidiomycetes, immune modulating effect, immunopotentiators, lectins, medicinal mushrooms, polysaccharides, terpenoids, antitumor substances
|Begell Digital Portal||Begell Digital Library||eBooks||Journals||References & Proceedings||Research Collections|